Advertisement Isolagen reports positive results from Phase II wrinkles trial - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Isolagen reports positive results from Phase II wrinkles trial

Isolagen has announced positive results from a prospective, open label, Phase II study of Isolagen therapy for the treatment of facial wrinkles and creases in approximately 40 subjects.

Study subjects received two treatments of Isolagen therapy in multiple facial regions approximately five weeks apart. The study results reported improvement in the appearance of wrinkles as scored by a high percentage both of study subjects as well as of independent panel evaluators.

The study results also reported improvement in skin quality as scored by a high percentage of both study subjects and participating investigators. Approximately six months following their final treatment 83% of subjects reported an improvement in their self-assessed score of the appearance of their wrinkles.

At the six-month time point, the results from the independent panel evaluation of study photographs also showed improvement in the appearance of wrinkles, with the independent panel scoring improvement in over 75% of participants.

The study also included an assessment of skin quality of the study subjects, comparing results from baseline to the final six-month visit. Using a skin quality assessment tool developed for this study, 93% of subjects said their skin quality improved. Additionally, more than 95% of subjects showed improvements in skin quality based on the treating investigator assessment.